The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain

Kim, HJu; Leeds, P; Chuang, DeMaw

HERO ID

1460623

Reference Type

Journal Article

Year

2009

Language

English

PMID

19549282

HERO ID 1460623
In Press No
Year 2009
Title The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain
Authors Kim, HJu; Leeds, P; Chuang, DeMaw
Journal Journal of Neurochemistry
Volume 110
Issue 4
Page Numbers 1226-1240
Abstract In the healthy adult brain, neurogenesis normally occurs in the subventricular zone (SVZ) and hippocampal dentate gyrus (DG). Cerebral ischemia enhances neurogenesis in neurogenic and non-neurogenic regions of the ischemic brain of adult rodents. This study demonstrated that post-insult treatment with a histone deacetylase inhibitor, sodium butyrate (SB), stimulated the incorporation of bromo-2'-deoxyuridine (BrdU) in the SVZ, DG, striatum, and frontal cortex in the ischemic brain of rats subjected to permanent cerebral ischemia. SB treatment also increased the number of cells expressing polysialic acid-neural cell adhesion molecule, nestin, glial fibrillary acidic protein, phospho-cAMP response element-binding protein (CREB), and brain-derived neurotrophic factor (BDNF) in various brain regions after cerebral ischemia. Furthermore, extensive co-localization of BrdU and polysialic acid-neural cell adhesion molecule was observed in multiple regions after ischemia, and SB treatment up-regulated protein levels of BDNF, phospho-CREB, and glial fibrillary acidic protein. Intraventricular injection of K252a, a tyrosine kinase B receptor antagonist, markedly reduced SB-induced cell proliferation detected by BrdU and Ki67 in the ipsilateral SVZ, DG, and other brain regions, blocked SB-induced nestin expression and CREB activation, and attenuated the long-lasting behavioral benefits of SB. Together, these results suggest that histone deacetylase inhibitor-induced cell proliferation, migration and differentiation require BDNF-tyrosine kinase B signaling and may contribute to long-term beneficial effects of SB after ischemic injury.
Doi 10.1111/j.1471-4159.2009.06212.x
Pmid 19549282
Wosid WOS:000268221500009
Is Certified Translation No
Dupe Override No
Comments Source: Web of Science WOS:000268221500009
Is Public Yes
Language Text English
Keyword brain-derived neurotrophic factor; bromo-2'-deoxyuridine; cerebral ischemia; histone deacetylase inhibitors; K252a; neurogenesis